VIDEO: Terns Pharma ‘builds upon pipeline’ of NASH, obesity research

In a Healio video exclusive, Diana Chung, chief development officer at Terns Pharmaceuticals, highlights data on TERN-501, a thyroid hormone receptor beta-agonist for patients with nonalcoholic steatohepatitis.At the 2022 International Liver Congress, Terns conducted five oral and poster presentations on data from three programs, including TERN-501, which recently was evaluated in the company’s first-in-human study….

Few PCPs implementing universal HBV vaccination guidance

It is finally possible to eliminate hepatitis B virus in the United States, as long as a multipronged strategy is used to fully implement new guidance that recommends universal vaccination for adults aged 19 to 59 years, experts said.This multipronged strategy includes increasing clinician awareness of the guidance, which is currently low, according to Rita…

Fatigue linked to worse clinical prognosis, quality of life in patients with NAFLD

LONDON — Lower fatigue scores at baseline correlated with adverse clinical events among patients with advanced nonalcoholic steatohepatitis, according to research presented at the International Liver Congress.“Fatigue is very common in patients with NAFLD. In other diseases, fatigue is associated with adverse outcomes, including higher mortality,” Zobair M. Younossi, MD, MPH, president of Inova Medicine…